tirzepatide 1.25 mg Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Decoding GLP-1 Weight Loss Medications

Oral semaglutide still helps reduce appetite and calorie intake, especially for those who prefer pills

Through personalized care and comprehensive evaluation, we ensure you receive a treatment plan tailored to your needs

Make sure to avoid using a tanning bed and sun exposure for about 24 hours before and after your treatment, but it is best to refrain from this for one to two weeks to help reduce the possibility of post-treatment lightening or darkening of your skin

Remember, consulting healthcare providers for personalized guidance is essential in managing any medication-related side effects effectively

Picconi, O., et al., Safety of oral alpha-lipoic acid treatment in pregnant women: a retrospective observational study

Erb, Holger HH, et al